Similar articles

• The kidney in systemic lupus erythematosus.

  Cameron JS, Turner DR, Vosnides G, Leibowitz S, Lessof MH, Ogg CS, Chantler C, Brown CB. Cameron JS, et al. Perspect Nephrol Hypertens. 1977;6:41-81. Perspect Nephrol Hypertens. 1977. PMID: 320552 Review. No abstract available.
• [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].

  Pigrau A, Martínez-Vázquez JM, Bacardí R, Ocanña I, Pahissa A. Pigrau A, et al. Med Clin (Barc). 1984 Dec 8;83(19):787-91. Med Clin (Barc). 1984. PMID: 6335542 Spanish. No abstract available.
• Lupus erythematosus.

  Schur PH. Schur PH. Adv Nephrol Necker Hosp. 1976;6:63-77. Adv Nephrol Necker Hosp. 1976. PMID: 65909 No abstract available.
• Some recent immunologic developments in the etiology and treatment of systemic lupus erythematosus.

  Zweiman B, Courter AJ. Zweiman B, et al. Del Med J. 1975 Jun;47(6):303-10. Del Med J. 1975. PMID: 1095433 No abstract available.
• Membranous glomerulopathy in systemic lupus erythematosus.

  Gonzalez-Dettoni H, Tron F. Gonzalez-Dettoni H, et al. Adv Nephrol Necker Hosp. 1985;14:347-64. Adv Nephrol Necker Hosp. 1985. PMID: 3919538 Review. No abstract available.